FDA permits marketing of transcranial magnetic stimulation for obsessive compulsive disorder Ruby Khatun Khatun22 Aug 2018 10:45 AM ISTThe U.S. Food and Drug Administration (FDA) permitted the marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for the treatment...
US health secretary says agency has power to eliminate drug rebates Ruby Khatun Khatun22 Aug 2018 9:30 AM ISTWASHINGTON: U.S. Health and Human Services Secretary Alex Azar said it was within his agency's power to eliminate rebates on prescription drug...
Regeneron's anti-blindness drug approved for less frequent treatments Ruby Khatun Khatun21 Aug 2018 10:00 AM ISTRegeneron said it had won U.S. Food and Drug Administration (USFDA) approval for less-frequent applications of its Eylea anti-blindness treatment,...
Roche's Alecensa latest beneficiary of faster China drug approvals Ruby Khatun Khatun21 Aug 2018 9:45 AM ISTZURICH: Roche’s Alecensa lung cancer medicine became the latest beneficiary of China’s efforts to speed up approvals in the world’s second-biggest...
Mexico says major drug lab busted with 50 tons of synthetics Ruby Khatun Khatun21 Aug 2018 9:30 AM ISTMEXICO CITY: Mexican authorities say they have busted a major narcotics lab in the northern state of Sinaloa with about 50 tons of synthetic drugs.A...
Illegal internet drugs pharmacy busted in Delhi, 4 held Ruby Khatun Khatun20 Aug 2018 10:45 AM ISTNew Delhi: An illegal internet pharmacy, allegedly shipping drugs to overseas locations like the US and Canada, based in Delhi has been busted by the...
Jubilant Life Sciences plans Rs 550 crore capex in FY19 Ruby Khatun Khatun20 Aug 2018 10:30 AM ISTMUMBAI: Pharma company Jubilant Life Sciences has earmarked Rs 550 crore for capital expenditure (capex) in the current financial year, a top company...
FDA approves Bristol-Myers Opdivo for small cell lung cancer Ruby Khatun Khatun20 Aug 2018 10:00 AM ISTBristol-Myers Squibb Co said the U.S. Food and Drug Administration approved its treatment, Opdivo, for patients whose lung cancer had progressed even...
OxyContin maker Purdue taps financial restructuring adviser - sources Ruby Khatun Khatun20 Aug 2018 9:45 AM ISTNEW YORK/BOSTON: OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its...
Trump pushes US lawsuit against drug companies over opioids Ruby Khatun Khatun20 Aug 2018 9:30 AM ISTWASHINGTON: U.S. President Donald Trump on Thursday again pressed U.S. Attorney General Jeff Sessions to sue drug companies over the nation’s ongoing...
Jaslok Hospital looks to handover its daily operations; Hospital Giants line up Ruby Khatun Khatun19 Aug 2018 12:39 PM ISTHospital giants Radiant Life Care, Malaysia's IHH Healthcare, Zydus Hospitals, and the Hinduja Group are considering a proposal to run daily...
Eisai sets price tag of about 17,000 dollar on liver cancer drug Ruby Khatun Khatun19 Aug 2018 10:00 AM ISTJapan’s Eisai Co Ltd said it would price its cancer drug Lenvima at about $17,000 for a month’s supply before discounts after the U.S. Food and Drug...
